Displaying 85 - 96 of 275
General Hepatology
5

Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
General Hepatology
4

Gore & Associates: Small TIPS for the right reason, right patient at the right time - ILC 2022

View
General Hepatology
4

Gore & Associates: Small TIPS for the right reason, right patient at the right time - ILC 2022

View
General Hepatology
4

Gore & Associates: Small TIPS for the right reason, right patient at the right time - ILC 2022

View
General Hepatology
4

Gore & Associates: Small TIPS for the right reason, right patient at the right time - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View
Displaying 85 - 96 of 275